| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.08 | 0.7 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.072 | 0.7 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |